Account
Sanofi SA has won U.S. approval for its multiple sclerosis pill Aubagio - one of the two treatments for the chronic disease that could return the French drugmaker to growth after several blockbuster drugs lost patent protection.The drug has been shown to be less effective than some rivals but has milder side effects and analysts say it could find favor among newly diagnosed patients. Around 35 percent to 40 percent of multiple sclerosis (MS) sufferers prefer to take no medication rather than face unwanted side effects."In a clinical trial, the relapse rate for patients using Aubagio was about 30 percent lower than the rate for those taking a placebo," Russell Katz, director of the Division of Neurology Products at the Food and Drug Administration, said in a statement on Wednesday.Aubagio is expected to launch on the U.S. market in a few weeks, a spokeswoman for Sanofi unit Genzyme said.Multiple sclerosis, which has no cure, affects 2.5 million people worldwide. It is a chronic, often d...
Multiple sclerosis (MS) is an autoimmune disease that affects approximately 400,000 people in the United States. Caused by damage to the myelin sheath – the protect...
People who get shingles are more likely to also develop multiple sclerosis , according to a study in Taiwan .Researchers found that people who developed shingles had...
No one is sure what causes multiple sclerosis , but a preliminary study out Monday hints that a combination of low sun exposure and the "kissing disease" mononucleos...
Biogen Idec Inc.'s oral drug for multiple sclerosis showed success in the first of two large clinical trials , moving the company closer to gaining a foothold in an ...
For those suffering from the autoimmune disorder multiple sclerosis, life alternates between almost symptomless periods of time and episodes of intense neurological ...
A new study has found that interferon beta, the most widely prescribed drug for the treatment of multiple sclerosis, is ineffective against stopping the progression ...
Alzheimer's, Parkinson's disease, multiple sclerosis and traumatic brain injury are four neurodegenerative disorders with very different – and very devastating – eff...
A chemical previously found to cause people to break out in blistery rashes when used on furniture upholstery now shows promise as a treatment for multiple sclerosis...
Despite a few well-publicized studies and many hopeful patients waiting for treatment, there is no good evidence that multiple sclerosis , or MS, is caused by a bloo...
Health regulators said on Monday they could not definitively link Novartis AG's multiple sclerosis pill Gilenya with the deaths of people who took the drug.The Food ...
For people suffering from debilitating autoimmune disorders such as multiple sclerosis , there is growing evidence that help may be at hand from an unusual source: p...
Having a stressful home or work environment doesn't make a person more likely to develop multiple sclerosis , hints a large new study.Previous research has suggested...
Multiple sclerosis (MS) is a chronic autoimmune disease in which a body’s immune cells mistakenly attack myelin — a protective sheath around nerve cells in the brain...
Botox injections may provide some relief from arm tremors caused by multiple sclerosis, according to a small study published Monday. Botulinum toxin type A is sold u...
Ann Romney acknowledged Sunday that being diagnosed with multiple sclerosis sent her into a "dark place" for an extended time, but that she pulled through with the l...
Cannabis capsules failed to slow the progression of multiple sclerosis in a large British study, dealing a blow to hopes that the drug could provide long-term benefi...
Novartis said Friday a patient treated with its multiple sclerosis (MS) pill Gilenya was diagnosed with a rare and often fatal brain disease.The Swiss drugmaker said...
People with multiple sclerosis have long said that smoking marijuana helps ease their painful muscle cramping. And a new clinical trial suggests they are not just bl...
Europe's drug regulator said it is reviewing the "benefits and risks" of Novartis' multiple-sclerosis drug Gilenya and recommended that doctors closely monitor the h...